Pulmotherapeutics

Pulmotherapeutics Inc

3 Investors
Biopharmaceutical respiratory therapies
TYLER, TX

Pulmotherapeutics Inc. is a biopharmaceutical company dedicated to creating innovative therapies for respiratory diseases. It focuses on developing advanced treatments for severe pulmonary conditions, making use of cutting-edge technology.

Products & Team

Inhaled Therapies

Respiratory therapeuticsSeed

Pulmotherapeutics Inc. leverages a proprietary technology platform aimed at efficiently delivering therapeutic agents directly to the lungs in the form of inhaled therapies. This approach enhances drug delivery efficiency, reduces systemic side effects, and improves patient convenience compared to traditional treatment methods.

Value Proposition

Offers targeted treatments for respiratory diseases, minimizing the drawbacks of conventional therapies and improving patient compliance.

Pain Points

Lack of effective therapies and the need for complex combination treatments.

Efficient drug delivery to the lungsReduced systemic side effectsImproved patient convenience through inhalationProprietary technology platform
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
TYLER, TX
Primary headquarters

Funding History

0
E

Equity Offering

March 2025
Unknown Amount
No Funding Limit
Use of Proceeds
The Chief Executive Officer would receive an estimated salary of $250,000